Daily as of 2 Nov 16:00 ET
- Price
- below both $30.25 vs 50 $31.96 / 200 $36.88
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐Death cross 15 Jun 2026 ยท projected 23 bars out ยท tested 3 bars
Vera Therapeutics, Inc. Class A (VERA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat below the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 5 Aug 2026 | ๐Death | 4-hour | 20 bars out | Not tested |
| 14 Jul 2026 | ๐จGolden | 4-hour | 26 bars out | 5 bar cross test |
| 15 Jun 2026 | ๐Death moderate | daily | 23 bars out | 3 bar cross test |
| 23 Mar 2026 | ๐Death | 4-hour | 29 bars out | 7 bar cross test |
| 22 Oct 2025 | ๐จGolden steep | daily | 27 bars out | Not tested |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.